Patents Assigned to Medical Research and Development Corporation
  • Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody
    Patent number: 11219672
    Abstract: A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: January 11, 2022
    Assignees: Medical Research and Development Corporation, Foundation for Biomedical Research and Innovation
    Inventors: Haruki Okamura, Kyosuke Yamanishi, Wen Li
  • Skin tumor removal and healing compositions and processes
    Patent number: 4515779
    Abstract: A composition which comprises principally powdered bloodroot powdered ginger root, and zinc chloride in relatively equal parts by weight, is applied in a number of treatments to skin lesions such as epithelioma tumors. After a short time, the growth comes out and a healing ointment comprising lard, lanolin, phenol and tannic acid powder is applied to the site until healing is effected.
    Type: Grant
    Filed: October 23, 1981
    Date of Patent: May 7, 1985
    Assignee: Arkansas Medical Research & Development Corporation
    Inventor: John Q. Elliott